Back to Search Start Over

Barriers and Advances in Kidney Preservation

Authors :
C. Steichen
S. Giraud
D. Bon
B. Barrou
L. Badet
E. Salamé
T. Kerforne
G. Allain
J. Roumy
C. Jayle
P. Hannaert
T. Hauet
R. Thuillier
Ischémie Reperfusion en Transplantation d’Organes Mécanismes et Innovations Thérapeutiques ( IRTOMIT)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Poitiers
Service de Biochimie [Poitiers]
Centre hospitalier universitaire de Poitiers (CHU Poitiers)
Département d'Anesthésie et Réanimation Chirurgicale [Poitiers]
CHU Poitiers, Service de chirurgie cardio-thoracique, Poitiers, 86000, France
IBiSA Plateforme, Plate-forme MOdélisation Préclinique - Innovation Chirurgicale et Technologique (MOPICT)
Institut National de la Recherche Agronomique (INRA)
Fédération Hospitalo-universitaire SUrvival oPtimization in ORgan Transplantation (FHU SUPORT)
Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS)-Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT)
CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-Ciblage individuel et prévention des risques de traitements immunosupresseurs et de la transplantation (IPPRITT)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-Institut National de la Santé et de la Recherche Médicale (INSERM)- Ischémie Reperfusion en Transplantation d’Organes Mécanismes et Innovations Thérapeutiques ( IRTOMIT)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Poitiers-Cellules Dendritiques, Immunomodulation et Greffes
Université de Tours-Université de Tours
Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT)
Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM)-Cellules Dendritiques, Immunomodulation et Greffes
Université de Tours (UT)-Université de Tours (UT)
Source :
BioMed Research International, BioMed Research International, Hindawi Publishing Corporation, 2018, 2018, pp.1-15. ⟨10.1155/2018/9206257⟩, BioMed Research International, Vol 2018 (2018)
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

Despite the fact that a significant fraction of kidney graft dysfunctions observed after transplantation is due to ischemia-reperfusion injuries, there is still no clear consensus regarding optimal kidney preservation strategy. This stems directly from the fact that as of yet, the mechanisms underlying ischemia-reperfusion injury are poorly defined, and the role of each preservation parameter is not clearly outlined. In the meantime, as donor demography changes, organ quality is decreasing which directly increases the rate of poor outcome. This situation has an impact on clinical guidelines and impedes their possible harmonization in the transplant community, which has to move towards changing organ preservation paradigms: new concepts must emerge and the definition of a new range of adapted preservation method is of paramount importance. This review presents existing barriers in transplantation (e.g., temperature adjustment and adequate protocol, interest for oxygen addition during preservation, and clear procedure for organ perfusion during machine preservation), discusses the development of novel strategies to overcome them, and exposes the importance of identifying reliable biomarkers to monitor graft quality and predict short and long-term outcomes. Finally, perspectives in therapeutic strategies will also be presented, such as those based on stem cells and their derivatives and innovative models on which they would need to be properly tested.

Details

Language :
English
ISSN :
23146133 and 23146141
Database :
OpenAIRE
Journal :
BioMed Research International, BioMed Research International, Hindawi Publishing Corporation, 2018, 2018, pp.1-15. ⟨10.1155/2018/9206257⟩, BioMed Research International, Vol 2018 (2018)
Accession number :
edsair.dedup.wf.001..21ac6c708d2003821ad2f86e55bb6384